RHC Asia-Pacific 2013 - Discover the new presentations from the second session.
In these 3 case-based presentations you can learn how to:
- conduct a personalised, step-by-step assessment of a patient presenting with "uncontrolled hypertension"
- better understand what information is key to conclude for resistant hypertension of secondary causes
- optimise the combinations of antihypertensive drugs before concluding to "resistant essential hypertension"
Vernon M.S. Oh (SINGAPORE)
T. Morgan (AUSTRALIA)
Exclusive Interview: Trefor Morgan on Patient Referral for Resistant Hypertension
The Concluding Remarks from the Chairmen of the Resistant Hypertension Course Asia Pacific 2013
Arterial hypertension is the single largest contributor to death worldwide. One in three adults (around 1 billion people) worldwide are affected and the number is expected to increase to 1.6 billion by 2025. Data from the World Health Organization (WHO) Southeast Asian regions indicate that the prevalence of hypertension (blood pressure ≥ 140/90mmHg) ranging from 5% to 47% in men and 7% to 38% in women causing up to 66% of cardiovascular diseases, including fatal ischemic heart disease and stroke. This finding underlines the vast impact that blood pressure-lowering strategies could have in this populous region.
|Access the first session: My patient presents with "uncontrolled hypertension": how to rule out all spurious resistant hypertension causes →|
|Access the third session: Is my “resistant hypertensive” patient a candidate for techniques targeting the sympathetic nervous system? →|